Artigos de revistas: "Proteins – Biotechnology"

1

Lilie, Hauke. "Designer proteins in biotechnology". EMBO reports 4, n.º 4 (14 de março de 2003): 346–51. http://dx.doi.org/10.1038/sj.embor.embor808.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Uhlén, Mathias, Göran Forsberg, Tomas Moks, Maris Hartmanis e Björn Nilsson. "Fusion proteins in biotechnology". Current Opinion in Biotechnology 3, n.º 4 (agosto de 1992): 363–69. http://dx.doi.org/10.1016/0958-1669(92)90164-e.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Hodgson, John. "Proteins, biotechnology and Society". Trends in Biotechnology 6, n.º 5 (maio de 1988): 79–80. http://dx.doi.org/10.1016/0167-7799(88)90059-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Peake, Ian. "Biotechnology of Plasma Proteins, Haemostasis, Thrombosis and Iron Proteins". Blood Coagulation & Fibrinolysis 2, n.º 6 (dezembro de 1991): 779. http://dx.doi.org/10.1097/00001721-199112000-00014.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Strege, Mark A., e Avinash L. Lagu. "Capillary electrophoresis of biotechnology-derived proteins". Electrophoresis 18, n.º 12-13 (1997): 2343–52. http://dx.doi.org/10.1002/elps.1150181225.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Jenkins, Richard O. "Proteins: Biotechnology and biochemistry: Walsh, G." Biochemistry and Molecular Biology Education 30, n.º 4 (julho de 2002): 271–72. http://dx.doi.org/10.1002/bmb.2002.494030049998.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Vizcaino-Caston, Isaac, Chris Wyre e Tim W. Overton. "Fluorescent proteins in microbial biotechnology—new proteins and new applications". Biotechnology Letters 34, n.º 2 (8 de outubro de 2011): 175–86. http://dx.doi.org/10.1007/s10529-011-0767-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Tami, Joseph A. "The Science of Biotechnology". Journal of Pharmacy Practice 11, n.º 1 (fevereiro de 1998): 19–27. http://dx.doi.org/10.1177/089719009801100105.

Texto completo da fonte

Resumo:

The quest to understand how genetic information is passed from one generation to the next reached a major milestone in the 1950s with the discovery of the complementary double-helix structure of DNA by Watson and Crick and the demonstration by Kornberg that DNA was capable of self-replication. These breakthroughs provided the stimulus for a flurry of research that culminated in a basic understanding of the genetic code and a statement of the central dogma of molecular biology: DNA goes to RNA goes to protein. In expressing a gene, RNA is formed from the DNA template in a process called transcription. The process of RNA forming protein is known as translation. During translation, amino acids are linked to form protein. The primary structure of proteins is thus determined by the sequence of amino acids. Using x-ray crystallography and computer imaging, it has been possible to determine the three-dimensional structure of many proteins and to design small molecule peptides which can either mimic or block the function of the protein and thus be useful therapeutic agents.

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Davies, J. E. "Biotechnology 1985: From proteins to small molecules". Experientia 42, n.º 1 (janeiro de 1986): 87–88. http://dx.doi.org/10.1007/bf01975911.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Šamaj, J. "Plant biotechnology employing signalling and cytoskeletal proteins". New Biotechnology 44 (outubro de 2018): S16. http://dx.doi.org/10.1016/j.nbt.2018.05.1252.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Nilsson, Björn, Göran Forsberg, Tomas Moks, Maris Hartmanis e Mathias Uhlén. "Fusion proteins in biotechnology and structural biology". Current Opinion in Structural Biology 2, n.º 4 (agosto de 1992): 569–75. http://dx.doi.org/10.1016/0959-440x(92)90087-n.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

NILSSON, B. "Fusion proteins in biotechnology and structural biology". Current Biology 2, n.º 9 (setembro de 1992): 476. http://dx.doi.org/10.1016/0960-9822(92)90663-u.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

AD, Suleimanova. "Microbial Biotechnology Based Modified Yeast". Open Access Journal of Microbiology & Biotechnology 5, n.º 1 (2020): 1–2. http://dx.doi.org/10.23880/oajmb-16000155.

Texto completo da fonte

Resumo:

The production of heterologous proteins, lipids and chemicals based on modified yeast is a rapidly developing area of microbial biotechnology. Methods of metabolic engineering and new technologies for editing genomes are used to create a fundamentally new high-performance industrially significant yeast strains with new properties.

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Dũng, Nguyễn Tiến, Đỗ Thị Vân Anh, Nguyễn Thị Minh Phương, Bùi Thị Huyền, Phạm Đình Minh, Đỗ Hữu Chí, Nguyễn Thị Phương Liên, Phan Văn Chi e Lê Thị Bích Thảo. "1Institute of Biotechnology, Vietnam Academy of Science and Technology". Vietnam Journal of Biotechnology 15, n.º 2 (20 de abril de 2018): 259–65. http://dx.doi.org/10.15625/1811-4989/15/2/12342.

Texto completo da fonte

Resumo:

Wasp venoms are complex mixtures of various types of compounds, of which proteins and peptides are major components. Beside its toxicity, wasp venom is potential for treatment of diseases. Characterization of venom proteins and peptides is the first and most important step toward its applications in medicine. Vietnam possesses many valuable materials, of which venoms could be used in medicine. In the present work, we aim to identify proteins and peptides in the venom of Vespa velutina (V. velutina), a species of social wasp indigenous to Southeast Asia including Vietnam using proteomic techniques. The venom isolated from V. velutina by manual extraction was digested with trypsin via the FASP (Filter Aided Sample Preparation) method and analyzed with liquid chromatography tandem - mass spectrometry (LC-MS/MS). The following protein identification, protein validation, and peptide de novo sequencing were carried out using the Peaks software. In total, we detected 36 proteins from V. velutina venom and many of them had been reported as venom-specific proteins. According to Gene Ontology Annotation (GOA), V. velutina venom proteins were functionally classified into five categories: binding proteins (53%), catalytic proteins (33%), structural proteins (8%), antioxidants (4%), and proteins with other functions (2%). In addition, 81 peptides were detected in the venom of V. velutina by de novo sequencing, of which 34 peptides (42%) are potential venom peptides. We introduced for the first time the collection of proteins and peptides from V. velutina venom, providing the basis for its further application in medicine.

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Prausnitz, J. M. "Molecular thermodynamics for some applications in biotechnology". Pure and Applied Chemistry 75, n.º 7 (1 de janeiro de 2003): 859–73. http://dx.doi.org/10.1351/pac200375070859.

Texto completo da fonte

Resumo:

As biotechnology sweeps the world, it is appropriate to remember that the great virtue of thermodynamics is its broad range of applicability. As a result, there is a growing literature describing how chemical thermodynamics can be used to inform processes for old and new biochemical products for industry and medicine.A particular application of molecular thermodynamics concerns separation of aqueous proteins by selective precipitation. For this purpose, we need phase diagrams; for constructing such diagrams, we need to understand not only the qualitative nature of phase equilibria of aqueous proteins, but also the quantitative intermolecular forces between proteins in solution. Some examples are given to show how aqueous protein-protein forces can be calculated or measured to yield a potential of mean force and how that potential is then used along with a statistical-thermodynamic model to establish liquid -liquid and liquid -crystal equilibria. Such equilibria are useful not only for separation processes, but also for understanding diseases like Alzheimer’s, eye cataracts, and sickle-cell anemia that appear to be caused by protein agglomeration.

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Beales, Paul A., Sanobar Khan, Stephen P. Muench e Lars J. C. Jeuken. "Durable vesicles for reconstitution of membrane proteins in biotechnology". Biochemical Society Transactions 45, n.º 1 (8 de fevereiro de 2017): 15–26. http://dx.doi.org/10.1042/bst20160019.

Texto completo da fonte

Resumo:

The application of membrane proteins in biotechnology requires robust, durable reconstitution systems that enhance their stability and support their functionality in a range of working environments. Vesicular architectures are highly desirable to provide the compartmentalisation to utilise the functional transmembrane transport and signalling properties of membrane proteins. Proteoliposomes provide a native-like membrane environment to support membrane protein function, but can lack the required chemical and physical stability. Amphiphilic block copolymers can also self-assemble into polymersomes: tough vesicles with improved stability compared with liposomes. This review discusses the reconstitution of membrane proteins into polymersomes and the more recent development of hybrid vesicles, which blend the robust nature of block copolymers with the biofunctionality of lipids. These novel synthetic vesicles hold great promise for enabling membrane proteins within biotechnologies by supporting their enhanced in vitro performance and could also contribute to fundamental biochemical and biophysical research by improving the stability of membrane proteins that are challenging to work with.

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Panchal, R., M. Smart, D. Bowser, D. Williams e S. Petrou. "Pore-Forming Proteins and their Application in Biotechnology". Current Pharmaceutical Biotechnology 3, n.º 2 (1 de junho de 2002): 99–115. http://dx.doi.org/10.2174/1389201023378418.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Zlobin, Nikolai E., e Vasiliy V. Taranov. "Application of bacterial cold shock proteins in biotechnology". Bulletin of the Moscow State Regional University (Natural Sciences), n.º 1 (2018): 86–94. http://dx.doi.org/10.18384/2310-7189-2018-1-86-94.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Ladics, Gregory. "Safety assessment of proteins utilized in agricultural biotechnology". Toxicology Letters 229 (setembro de 2014): S25. http://dx.doi.org/10.1016/j.toxlet.2014.06.123.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Service, R. F. "BIOTECHNOLOGY: Yeast Engineered to Produce Sugared Human Proteins". Science 301, n.º 5637 (29 de agosto de 2003): 1171. http://dx.doi.org/10.1126/science.301.5637.1171.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Lehrer, Samuel B., W. Elliott Horner, Gerald Reese e Steven Taylor. "Why are some proteins allergenic? Implications for biotechnology". Critical Reviews in Food Science and Nutrition 36, n.º 6 (julho de 1996): 553–64. http://dx.doi.org/10.1080/10408399609527739.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Lynch, Thomas J. "Biotechnology: alternatives to human plasma-derived therapeutic proteins". Best Practice & Research Clinical Haematology 13, n.º 4 (dezembro de 2000): 669–88. http://dx.doi.org/10.1053/beha.2000.0100.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Aebersold, Ruedi. "Mass spectrometry of proteins and peptides in biotechnology". Current Opinion in Biotechnology 4, n.º 4 (agosto de 1993): 412–19. http://dx.doi.org/10.1016/0958-1669(93)90006-i.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Mrsa, Vladimir, Antonija Grbavac, Igor Stuparevic e Renata Teparic. "Application of surface display of proteins in biotechnology". Journal of Biotechnology 256 (agosto de 2017): S12—S13. http://dx.doi.org/10.1016/j.jbiotec.2017.06.044.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Yakimov, A. P., A. S. Afanaseva, M. A. Khodorkovskiy e M. G. Petukhov. "Design of Stable α-Helical Peptides and Thermostable Proteins in Biotechnology and Biomedicine". Acta Naturae 8, n.º 4 (15 de dezembro de 2016): 70–81. http://dx.doi.org/10.32607/20758251-2016-8-4-70-81.

Texto completo da fonte

Resumo:

-Heliсes are the most frequently occurring elements of the secondary structure in water-soluble globular proteins. Their increased conformational stability is among the main reasons for the high thermal stability of proteins in thermophilic bacteria. In addition, -helices are often involved in protein interactions with other proteins, nucleic acids, and the lipids of cell membranes. That is why the highly stable -helical peptides used as highly active and specific inhibitors of protein-protein and other interactions have recently found more applications in medicine. Several different approaches have been developed in recent years to improve the conformational stability of -helical peptides and thermostable proteins, which will be discussed in this review. We also discuss the methods for improving the permeability of peptides and proteins across cellular membranes and their resistance to intracellular protease activity. Special attention is given to the SEQOPT method (http://mml.spbstu.ru/services/seqopt/), which is used to design conformationally stable short -helices.

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Niemeyer, Christof M. "Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science". Angewandte Chemie International Edition 40, n.º 22 (16 de novembro de 2001): 4128–58. http://dx.doi.org/10.1002/1521-3773(20011119)40:22<4128::aid-anie4128>3.0.co;2-s.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Graf, Alexandra, Martin Dragosits, Brigitte Gasser e Diethard Mattanovich. "Yeast systems biotechnology for the production of heterologous proteins". FEMS Yeast Research 9, n.º 3 (maio de 2009): 335–48. http://dx.doi.org/10.1111/j.1567-1364.2009.00507.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Peumans, Willy J., e Els J. M. Van Damme. "Plant Lectins: Versatile Proteins with Important Perspectives in Biotechnology". Biotechnology and Genetic Engineering Reviews 15, n.º 1 (abril de 1998): 199–228. http://dx.doi.org/10.1080/02648725.1998.10647956.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Kennedy, John F., e Yu-Tien Lin. "Industrial Proteins in Perspective—Progress in Biotechnology Vol. 23". Carbohydrate Polymers 55, n.º 1 (janeiro de 2004): 118. http://dx.doi.org/10.1016/j.carbpol.2003.08.013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Kumar, Awanish, Kavya Bhakuni e Pannuru Venkatesu. "Strategic planning of proteins in ionic liquids: future solvents for the enhanced stability of proteins against multiple stresses". Physical Chemistry Chemical Physics 21, n.º 42 (2019): 23269–82. http://dx.doi.org/10.1039/c9cp04772g.

Texto completo da fonte

Resumo:

Ionic liquids (ILs) represent as solvents or co-solvents for protein stabilization and refolding. Thus, ILs are replacement to toxic organic solvents in chemical, biotechnology and biomedical applications.

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Ningrum, Dian Eka A. F., Mohamad Amin e Betty Lukiati. "Bioinformatics Approach Based Research of Profile Protein Carbonic Anhydrase II Analysis as a Potential Candidate Cause Autism for The Variation of Learning Subjects Biotechnology". Jurnal Pendidikan Biologi Indonesia 3, n.º 1 (31 de março de 2017): 28. http://dx.doi.org/10.22219/jpbi.v3i1.3799.

Texto completo da fonte

Resumo:

This study aims to determine the needs of learning variations on Biotechnology courses using bioinformatics approaches. One example of applied use of bioinformatics in biotechnology course is the analysis of protein profiles carbonic anhydrase II as a potential cause of autism candidate. This research is a qualitative descriptive study consisted of two phases. The first phase of the data obtained from observations of learning, student questionnaires, and questionnaires lecturer. Results from the first phase, namely the need for variations learning in Biotechnology course using bioinformatics. Collecting data on the second stage uses three webserver to predict the target protein and scientific articles. Visualization of proteins using PyMOL software. 3 based webserver which is used, the candidate of target proteins associated with autism is carbonic anhydrase II. The survey results revealed that the protein carbonic anhydrase II as a potential candidate for the cause of autism classified metaloenzim are able to bind with heavy metals. The content of heavy metals in autistic patients high that affect metabolism. This prediction of protein candidate cause autism is applied use to solve the problem in society, so that can achieve the learning outcome in biotechnology course.

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Mitchell, Daniel E., Alice E. R. Fayter, Robert C. Deller, Muhammad Hasan, Jose Gutierrez-Marcos e Matthew I. Gibson. "Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage". Materials Horizons 6, n.º 2 (2019): 364–68. http://dx.doi.org/10.1039/c8mh00727f.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Haque, R. U., F. Paradisi e T. Allers. "Haloferax volcanii for biotechnology applications: challenges, current state and perspectives". Applied Microbiology and Biotechnology 104, n.º 4 (20 de dezembro de 2019): 1371–82. http://dx.doi.org/10.1007/s00253-019-10314-2.

Texto completo da fonte

Resumo:

AbstractHaloferax volcanii is an obligate halophilic archaeon with its origin in the Dead Sea. Simple laboratory culture conditions and a wide range of genetic tools have made it a model organism for studying haloarchaeal cell biology. Halophilic enzymes of potential interest to biotechnology have opened up the application of this organism in biocatalysis, bioremediation, nanobiotechnology, bioplastics and the biofuel industry. Functionally active halophilic proteins can be easily expressed in a halophilic environment, and an extensive genetic toolkit with options for regulated protein overexpression has allowed the purification of biotechnologically important enzymes from different halophiles in H. volcanii. However, corrosion mediated damage caused to stainless-steel bioreactors by high salt concentrations and a tendency to form biofilms when cultured in high volume are some of the challenges of applying H. volcanii in biotechnology. The ability to employ expressed active proteins in immobilized cells within a porous biocompatible matrix offers new avenues for exploiting H. volcanii in biotechnology. This review critically evaluates the various application potentials, challenges and toolkits available for using this extreme halophilic organism in biotechnology.

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Geisow, Michael J. "Characterizing Recombinant Proteins". Bio/Technology 9, n.º 10 (outubro de 1991): 921–24. http://dx.doi.org/10.1038/nbt1091-921.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Nchinda, Godwin W., Nadia Al-Atoom, Mamie T. Coats, Jacqueline M. Cameron e Alain B. Waffo. "Uniqueness of RNA Coliphage Qβ Display System in Directed Evolutionary Biotechnology". Viruses 13, n.º 4 (27 de março de 2021): 568. http://dx.doi.org/10.3390/v13040568.

Texto completo da fonte

Resumo:

Phage display technology involves the surface genetic engineering of phages to expose desirable proteins or peptides whose gene sequences are packaged within phage genomes, thereby rendering direct linkage between genotype with phenotype feasible. This has resulted in phage display systems becoming invaluable components of directed evolutionary biotechnology. The M13 is a DNA phage display system which dominates this technology and usually involves selected proteins or peptides being displayed through surface engineering of its minor coat proteins. The displayed protein or peptide’s functionality is often highly reduced due to harsh treatment of M13 variants. Recently, we developed a novel phage display system using the coliphage Qβ as a nano-biotechnology platform. The coliphage Qβ is an RNA phage belonging to the family of Leviviridae, a long investigated virus. Qβ phages exist as a quasispecies and possess features making them comparatively more suitable and unique for directed evolutionary biotechnology. As a quasispecies, Qβ benefits from the promiscuity of its RNA dependent RNA polymerase replicase, which lacks proofreading activity, and thereby permits rapid variant generation, mutation, and adaptation. The minor coat protein of Qβ is the readthrough protein, A1. It shares the same initiation codon with the major coat protein and is produced each time the ribosome translates the UGA stop codon of the major coat protein with the of misincorporation of tryptophan. This misincorporation occurs at a low level (1/15). Per convention and definition, A1 is the target for display technology, as this minor coat protein does not play a role in initiating the life cycle of Qβ phage like the pIII of M13. The maturation protein A2 of Qβ initiates the life cycle by binding to the pilus of the F+ host bacteria. The extension of the A1 protein with a foreign peptide probe recognizes and binds to the target freely, while the A2 initiates the infection. This avoids any disturbance of the complex and the necessity for acidic elution and neutralization prior to infection. The combined use of both the A1 and A2 proteins of Qβ in this display system allows for novel bio-panning, in vitro maturation, and evolution. Additionally, methods for large library size construction have been improved with our directed evolutionary phage display system. This novel phage display technology allows 12 copies of a specific desired peptide to be displayed on the exterior surface of Qβ in uniform distribution at the corners of the phage icosahedron. Through the recently optimized subtractive bio-panning strategy, fusion probes containing up to 80 amino acids altogether with linkers, can be displayed for target selection. Thus, combined uniqueness of its genome, structure, and proteins make the Qβ phage a desirable suitable innovation applicable in affinity maturation and directed evolutionary biotechnology. The evolutionary adaptability of the Qβ phage display strategy is still in its infancy. However, it has the potential to evolve functional domains of the desirable proteins, glycoproteins, and lipoproteins, rendering them superior to their natural counterparts.

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Tami, Joseph A. "Major Techniques of Biotechnology". Journal of Pharmacy Practice 11, n.º 1 (fevereiro de 1998): 28–37. http://dx.doi.org/10.1177/089719009801100106.

Texto completo da fonte

Resumo:

Since the discovery of the structure and function of DNA over 40 years ago, the established knowledge of molecular biology has increased dramatically, and many new tools have been discovered and utilized by scientists to develop new therapeutic agents. Important tools that are used in recombinant DNA technology include restriction endonucleases (cleave DNA), DNA ligase (link DNA molecules together), and cloning vectors (place foreign DNA into an organism such as bacterial or yeast cells in order to mass produce the protein encoded by that foreign DNA). The development of hybridoma technology provided a method to produce virtually unlimited quantities of pure antibody with a single specificity. These immuno-globulins are known as monoclonal antibodies, and have provided both therapeutic and diagnostic agents. Antisense molecules are oligonucleotides which bind to the messenger RNA (mRNA) of a target gene and selectively inhibit the production of specific proteins. Potential applications for these molecules include cancer and viral and inflammatory diseases. The more recent development of the polymerase chain reaction (PCR) has provided a tool that has revolutionized diagnostic testing in diverse areas such as infectious diseases, genetic abnormalities, and cancer.

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Gonzalez-Vazquez, Maria Cristina, Ruth Abril Vela-Sanchez, Norma Elena Rojas-Ruiz e Alejandro Carabarin-Lima. "Importance of Cry Proteins in Biotechnology: Initially a Bioinsecticide, Now a Vaccine Adjuvant". Life 11, n.º 10 (23 de setembro de 2021): 999. http://dx.doi.org/10.3390/life11100999.

Texto completo da fonte

Resumo:

A hallmark of Bacillus thuringiensis bacteria is the formation of one or more parasporal crystal (Cry) proteins during sporulation. The toxicity of these proteins is highly specific to insect larvae, exerting lethal effects in different insect species but not in humans or other mammals. The aim of this review is to summarize previous findings on Bacillus thuringiensis, including the characteristics of the bacterium, its subsequent contribution to biotechnology as a bioinsecticide due to the presence of Cry proteins, and its potential application as an adjuvant. In several studies, Cry proteins have been administered together with specific antigens to immunize experimental animal models. The results have shown that these proteins can enhance immunogenicity by generating an adequate immune response capable of protecting the model against an experimental infectious challenge, whereas protection is decreased when the specific antigen is administered without the Cry protein. Therefore, based on previous results and the structural homology between Cry proteins, these molecules have arisen as potential adjuvants in the development of vaccines for both animals and humans. Finally, a model of the interaction of Cry proteins with different components of the immune response is proposed.

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Han, Mee-Jung, Hongseok Yun e Sang Yup Lee. "Microbial small heat shock proteins and their use in biotechnology". Biotechnology Advances 26, n.º 6 (novembro de 2008): 591–609. http://dx.doi.org/10.1016/j.biotechadv.2008.08.004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Kriz, Alan L., e Brian A. Larkins. "Biotechnology of Seed Crops: Genetic Engineering of Seed Storage Proteins". HortScience 26, n.º 8 (agosto de 1991): 1036–41. http://dx.doi.org/10.21273/hortsci.26.8.1036.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Amtul, Zareen, e Amal A. Aziz. "Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy". Molecular Neurobiology 54, n.º 10 (1 de dezembro de 2016): 8211–24. http://dx.doi.org/10.1007/s12035-016-0279-3.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

King, David J. "High-performance liquid chromatography of proteins and peptides in biotechnology". TrAC Trends in Analytical Chemistry 6, n.º 5 (maio de 1987): X—XI. http://dx.doi.org/10.1016/0165-9936(87)87050-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Fleurence, Joël. "Seaweed proteins". Trends in Food Science & Technology 10, n.º 1 (janeiro de 1999): 25–28. http://dx.doi.org/10.1016/s0924-2244(99)00015-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Park, Jae W. "Seafood proteins". Trends in Food Science & Technology 5, n.º 12 (dezembro de 1994): 408. http://dx.doi.org/10.1016/0924-2244(94)90176-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Selitrennikoff, Claude P. "Antifungal Proteins". Applied and Environmental Microbiology 67, n.º 7 (1 de julho de 2001): 2883–94. http://dx.doi.org/10.1128/aem.67.7.2883-2894.2001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

GIEGE, R. "Crystallogenesis of proteins". Trends in Biotechnology 7, n.º 10 (outubro de 1989): 277–82. http://dx.doi.org/10.1016/0167-7799(89)90047-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Bush, Peggy. "Pharmacotherapeutics of Biotechnology-Derived Products". Journal of Pharmacy Practice 11, n.º 1 (fevereiro de 1998): 54–71. http://dx.doi.org/10.1177/089719009801100109.

Texto completo da fonte

Resumo:

Biotechnology has contributed to important advances in the healthcare field. Products include various hormones, enzymes, cytokines, vaccines, and monoclonal antibodies, with use in diverse therapeutic areas. The majority of approved biotechnology-derived therapeutic products are recombinant proteins. Many have orphan drug status and, therefore, are used in relatively small patient populations. Newer generation biotechnology products are likely to include small molecules, gene therapy products, and increased numbers of vaccines and monoclonal antibody products. Biotechnology provides the means to develop diverse, innovative, and effective approaches to the prevention, treatment, and cure of human disease.

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Morley, Alec. "Biotechnology: Proteins to PCR—a course in strategies and lab techniques". Pathology 29, n.º 4 (1997): 453. http://dx.doi.org/10.1016/s0031-3025(16)35008-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Nixon, Andrew E., e Steven M. Firestine. "Rational and “Irrational” Design of Proteins and Their Use in Biotechnology". IUBMB: Life 49, n.º 3 (1 de março de 2000): 181–87. http://dx.doi.org/10.1080/152165400306188.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Nixon, Andrew, e Steven Firestine. "Rational and ?Irrational? Design of Proteins and Their Use in Biotechnology". IUBMB Life 49, n.º 3 (1 de março de 2000): 181–87. http://dx.doi.org/10.1080/713803615.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Strege, Mark A., e Avinash L. Lagu. "Capillary electrophoretic separations of biotechnology-derived proteins inE. coli fermentation broth". Electrophoresis 16, n.º 1 (1995): 642–46. http://dx.doi.org/10.1002/elps.11501601103.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Artigos de revistas sobre o tema "Proteins – Biotechnology"

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos